SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-076154
Filing Date
2020-06-24
Accepted
2020-06-23 18:56:00
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014603-1_10q.htm 10-Q 626471
2 EXHIBIT 31.1 tm2014603d1_ex31-1.htm EX-31.1 10099
3 EXHIBIT 32.1 tm2014603d1_ex32-1.htm EX-32.1 5222
  Complete submission text file 0001104659-20-076154.txt   7107950

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nwbo-20200331.xml EX-101.INS 2281506
5 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20200331.xsd EX-101.SCH 49397
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nwbo-20200331_cal.xml EX-101.CAL 46448
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nwbo-20200331_def.xml EX-101.DEF 186109
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20200331_lab.xml EX-101.LAB 352700
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20200331_pre.xml EX-101.PRE 332695
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 20983455
SIC: 2834 Pharmaceutical Preparations